PIRAMAL PHARMA
Back to Balance Sheet
|
PIRAMAL PHARMA Last 5 Year Sundry Debtors History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹2,350 Cr | ₹2,134 Cr | ₹1,799 Cr | ₹1,785 Cr | ₹1,575 Cr |
What is the latest Sundry Debtors ratio of PIRAMAL PHARMA ?
| Year | Sundry Debtors |
|---|---|
| Mar2025 | ₹2,350 Cr |
| Mar2024 | ₹2,134 Cr |
| Mar2023 | ₹1,799 Cr |
| Mar2022 | ₹1,785 Cr |
| Mar2021 | ₹1,575 Cr |
How is Sundry Debtors of PIRAMAL PHARMA Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,350 Cr | 10.08 | |
| Mar2024 | ₹2,134 Cr | 18.62 | |
| Mar2023 | ₹1,799 Cr | 0.79 | |
| Mar2022 | ₹1,785 Cr | 13.36 | |
| Mar2021 | ₹1,575 Cr | - | |
Compare Sundry Debtors of peers of PIRAMAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PIRAMAL PHARMA | ₹21,393.5 Cr | -1.1% | 4.3% | -20.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹423,195.0 Cr | 3% | 9.5% | 3.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,849.0 Cr | 1.7% | 3.1% | 5.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,586.0 Cr | 4.7% | 11.7% | 41.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,054.0 Cr | 2.1% | 6.7% | 11.6% | Stock Analytics | |
| CIPLA | ₹108,703.0 Cr | 1.3% | 1.3% | -9.4% | Stock Analytics | |
PIRAMAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PIRAMAL PHARMA | -1.1% |
4.3% |
-20.4% |
| SENSEX | -1.7% |
0.5% |
8.3% |
You may also like the below Video Courses